Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality, with high rates of post‐resection recurrence posing significant clinical challenges. Early recurrence is largely driven by aggressive tumor biology, while late recurrence reflects de novo carcinogenesis in a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jia‐Hao Law, Huilin Shao, Ramanuj DasGupta, Daniel Q. Huang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-08-01
Edice:	Clinical and Translational Medicine
Témata:	HCC biomarkers hepatocellular carcinoma recurrence risk stratification HCC
On-line přístup:	https://doi.org/10.1002/ctm2.70410
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!